Browsing by Subject Vaccine

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)
2013Mycobacterium tuberculosis antigen 85B and ESAT-6 expressed as a recombinant fusion protein in Mycobacterium smegmatis elicits cell-mediated immune response in a murine vaccination modelTsolaki, AG; Nagy, J; Leiva, S; Kishore, U; Rosenkrands, I; Robertson, BD
31-Jan-2019Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cellsTanner, R; Smith, SG; van Meijgaarden, KE; Giannoni, F; Wilkie, M; Gabriele, L; Palma, C; Dockrell, HM; Ottenhoff, THM; McShane, H
2012A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicityRowland, R; Brittain, N; Poulton, ID; Minassian, AM; Sander, C; Porter, DW; Satti, I; Pathan, AA; Lawrie, AM; McShane, H; Williams, N
2009Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in mycobacterium tuberculosis–infected individualsSander, CR; Pathan, AA; Beveridge, NER; Poulton, I; Minassian, A; Alder, N; Van Wijgerden, J; Hill, AVS; Gleeson, FV; Davies, RJO; Pasvol, G; McShane, H
2012SARS CoV subunit vaccine: Antibodymediated neutralisation and enhancementJaume, M; Yip, MS; Kam, YW; Cheung, CY; Kien, F; Roberts, A; Li, PH; Dutry, I; Escriou, N; Daeron, M; Bruzzone, R; Subbarao, K; Peiris, JSM; Nal, B; Altmeyer, R
2014Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A.Tanner, R; Kakalacheva, K; Miller, E; Pathan, AA; Chalk, R; Sander, CR; Scriba, T; Tameris, M; Hawkridge, T; Mahomed, H; Hussey, G; Hanekom, W; Checkley, A; McShane, H; Fletcher, HA